Epinephrine for first-aid management of anaphylaxis

Pediatrics

Volumn 139, Issue 3, 2017, Pages

  Sicherer, Scott H ^a   Simons, F Estelle R ^b   Mahr, Todd A ^c   Abramson, Stuart L ^c   Dinakar, Chitra ^c   Fleisher, Thomas A ^c   Irani, Anne Marie ^c   Kim, Jennifer S ^c   Matsui, Elizabeth C ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPINEPHRINE; BRONCHODILATING AGENT;

ANAPHYLAXIS; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SAFETY; FATALITY; HIGH RISK PATIENT; HUMAN; MORTALITY; PRESCRIPTION; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT PLANNING; CHILD; DEVICES; DOSE RESPONSE; DRUG SELF ADMINISTRATION; EMERGENCY HEALTH SERVICE; FIRST AID; INTRAMUSCULAR DRUG ADMINISTRATION; PATIENT EDUCATION; PRACTICE GUIDELINE; SCHOOL HEALTH SERVICE; STANDARDS; UNITED STATES;

ANAPHYLAXIS; BRONCHODILATOR AGENTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; EMERGENCY MEDICAL TAGS; EPINEPHRINE; FIRST AID; HUMANS; INJECTIONS, INTRAMUSCULAR; PATIENT EDUCATION AS TOPIC; SCHOOL HEALTH SERVICES; SELF ADMINISTRATION; UNITED STATES;

EID: 85016048280     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-4006     Document Type: Article

References (63)

1. Simons FER, Ardusso LRF, Bilo MB, et al.. World Allergy Organization guidelines for the assessment and management of anaphylaxis. J Allergy Clin Immunol. 2011;127:587-593, e1-e22
2. Lieberman P, Nicklas RA, Randolph C, et al.. Anaphylaxis-a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341-384
3. Sampson HA, Munoz-Furlong A, Campbell RL, et al.. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol. 2006;117(2):391-397
4. Sicherer SH, Simons FER; Section on Allergy and Immunology. Selfinjectable epinephrine for first-aid management of anaphylaxis [published correction appears in Pediatrics. 2007;119(6):1271]. Pediatrics. 2007;119(3):638-646
5. Campbell RL, Hagan JB, Manivannan V, et al.. Evaluation of National Institute of Allergy and Infectious Diseases/ Food Allergy and Anaphylaxis Network criteria for the diagnosis of anaphylaxis in emergency department patients. J Allergy Clin Immunol. 2012;129(3):748-752
6. Simons FER, Sampson HA. Anaphylaxis: unique aspects of clinical diagnosis and management in infants (birth to age 2 years). J Allergy Clin Immunol. 2015;135(5):1125-1131
7. Rudders SA, Banerji A, Clark S, Camargo CA Jr. Age-related differences in the clinical presentation of foodinduced anaphylaxis. J Pediatr. 2011;158(2):326-328
8. Boyce JA, Assa'ad A, Burks AW, et al.; NIAID-Sponsored Expert Panel. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAIDsponsored expert panel. J Allergy Clin Immunol. 2010;126(6 suppl):S1-S58
9. Sicherer SH, Sampson HA. Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol. 2014;133(2):291-307; quiz: 308
10. Golden DB, Moffitt J, Nicklas RA, et al.; Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma & Immunology); Joint Council of Allergy, Asthma and Immunology. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol. 2011;127(4):852-854.e1-e23
11. Romano A, Caubet JC. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. J Allergy Clin Immunol Pract. 2014;2(1):3-12
12. Kelso JM, Greenhawt MJ, Li JT, et al.. Adverse reactions to vaccines: practice parameter 2012 update. J Allergy Clin Immunol. 2012;130(1):25-43
13. Wolbing F, Fischer J, Koberle M, Kaesler S, Biedermann T. About the role and underlying mechanisms of cofactors in anaphylaxis. Allergy. 2013;68(9):1085-1092
14. Ansley L, Bonini M, Delgado L, et al.. Pathophysiological mechanisms of exercise-induced anaphylaxis: an EAACI position statement. Allergy. 2015;70(10):1212-1221
15. Bauer CS, Kampitak T, Messieh ML, Kelly KJ, Vadas P. Heterogeneity in presentation and treatment of catamenial anaphylaxis. Ann Allergy Asthma Immunol. 2013;111(2):107-111
16. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001;107(1):191-193
17. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol. 2007;119(4):1016-1018
18. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327(6):380-384
19. Sheikh A, Simons FER, Barbour V, Worth A. Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community. Cochrane Database Syst Rev. 2012;8:CD008935
20. Simons FER, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol. 1998;101(1 pt 1):33-37
21. Simons FER. First-aid treatment of anaphylaxis to food: focus on epinephrine [published correction appears in J Allergy Clin Immunol. 2004;113(6):1039]. J Allergy Clin Immunol. 2004;113(5):837-844
22. Fleming JT, Clark S, Camargo CA Jr, Rudders SA. Early treatment of foodinduced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. J Allergy Clin Immunol Pract. 2015;3(1):57-62
23. Simons KJ, Simons FER. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol. 2010;10(4):354-361
24. Simons FER. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol. 2006;117(2):367-377
25. Sheikh A, Ten Broek V, Brown SG, Simons FER. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2007;62(8):830-837
26. Park JH, Godbold JH, Chung D, Sampson HA, Wang J. Comparison of cetirizine and diphenhydramine in the treatment of acute food-induced allergic reactions. J Allergy Clin Immunol. 2011;128(5):1127-1128
27. Nurmatov UB, Rhatigan E, Simons FER, Sheikh A. H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic review. Ann Allergy Asthma Immunol. 2014;112(2):126-131
28. Choo KJL, Simons FER, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev. 2012;4:CD007596
29. Huang F, Chawla K, Jarvinen KM, Nowak-Wegrzyn A. Anaphylaxis in a New York City pediatric emergency department: triggers, treatments, and outcomes. J Allergy Clin Immunol. 2012;129(1):162-168.e1-e3
30. Jarvinen KM, Sicherer SH, Sampson HA, Nowak-Wegrzyn A. Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol. 2008;122(1):133-138
31. Rudders SA, Geyer BC, Banerji A, Phipatanakul W, Clark S, Camargo CA Jr. Obesity is not a risk factor for repeat epinephrine use in the treatment of anaphylaxis. J Allergy Clin Immunol. 2012;130(5):1216-1218
32. Mehr S, Liew WK, Tey D, Tang ML. Clinical predictors for biphasic reactions in children presenting with anaphylaxis. Clin Exp Allergy. 2009;39(9):1390-1396
33. Lee S, Bellolio MF, Hess EP, Erwin P, Murad MH, Campbell RL. Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2015;3(3):408-16. e1, e2
34. Campbell RL, Bellolio MF, Knutson BD, et al.. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract. 2015;3(1):76-80
35. Sicherer SH, Simons FER. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol. 2005;115(3):575-583
36. Simons FER, Chan ES, Gu X, Simons KJ. Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: is the ampule/syringe/ needle method practical? J Allergy Clin Immunol. 2001;108(6):1040-1044
37. Rawas-Qalaji M, Simons FER, Collins D, Simons KJ. Long-term stability of epinephrine dispensed in unsealed syringes for the first-aid treatment of anaphylaxis. Ann Allergy Asthma Immunol. 2009;102(6):500-503
38. Sicherer SH, Forman JA, Noone SA. Use assessment of self-administered epinephrine among food-allergic children and pediatricians. Pediatrics. 2000;105(2):359-362
39. Muraro A, Roberts G, Worm M, et al.; EAACI Food Allergy and Anaphylaxis Guidelines Group. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026-1045
40. Simons FER, Gu X, Silver NA, Simons KJ. EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis. J Allergy Clin Immunol. 2002;109(1):171-175
41. Simons FER, Clark S, Camargo CA Jr. Anaphylaxis in the community: learning from the survivors. J Allergy Clin Immunol. 2009;124(2):301-306
42. Campbell RL, Park MA, Kueber MA Jr, Lee S, Hagan JB. Outcomes of allergy/immunology follow-up after an emergency department evaluation for anaphylaxis. J Allergy Clin Immunol Pract. 2015;3(1):88-93
43. Boyle RJ, Elremeli M, Hockenhull J, et al.. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev. 2012;10:CD008838
44. Clark S, Wei W, Rudders SA, Camargo CA Jr. Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. J Allergy Clin Immunol. 2014;134(5):1125-1130
45. Noimark L, Wales J, Du Toit G, et al.. The use of adrenaline autoinjectors by children and teenagers. Clin Exp Allergy. 2012;42(2):284-292
46. Fleischer DM, Perry TT, Atkins D, et al.. Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics. 2012;130(1). Available at:www.pediatrics.org/cgi/content/full/130/1/e25
47. Chad L, Ben-Shoshan M, Asai Y, et al.. A majority of parents of children with peanut allergy fear using the epinephrine auto-injector. Allergy. 2013;68(12):1605-1609
48. Simons FER, Edwards ES, Read EJ Jr, Clark S, Liebelt EL. Voluntarily reported unintentional injections from epinephrine auto-injectors. J Allergy Clin Immunol. 2010;125(2):419-423, e4
49. Brown JC, Tuuri RE, Akhter S, et al.. Lacerations and embedded needles caused by epinephrine autoinjector use in children. Ann Emerg Med. 2015;67(3):307-315.e8
50. Muraro A, Agache I, Clark A, et al.; European Academy of Allergy and Clinical Immunology. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community. Allergy. 2014;69(8):1046-1057
51. Bonds RS, Asawa A, Ghazi AI. Misuse of medical devices: a persistent problem in self-management of asthma and allergic disease. Ann Allergy Asthma Immunol. 2015;114(1):74-76.e2
52. Topal E, Bakirtas A, Yilmaz O, et al.. When should we perform a repeat training on adrenaline autoinjector use for physician trainees? Allergol Immunopathol (Madr). 2014;42(5):472-475
53. Camargo CA Jr, Guana A, Wang S, Simons FE. Auvi-Q versus EpiPen: preferences of adults, caregivers, and children. J Allergy Clin Immunol Pract. 2013;1(3):266-272.e1-e3
54. Umasunthar T, Procktor A, Hodes M, et al.. Patients' ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial. Allergy. 2015;70(7):855-863
55. Simons E, Sicherer SH, Simons FER. Timing the transfer of responsibilities for anaphylaxis recognition and use of an epinephrine auto-injector from adults to children and teenagers: pediatric allergists' perspective. Ann Allergy Asthma Immunol. 2012;108(5):321-325
56. Simons E, Sicherer SH, Weiss C, Simons FER. Caregivers' perspectives on timing the transfer of responsibilities for anaphylaxis recognition and treatment from adults to children and teenagers. J Allergy Clin Immunol Pract. 2013;1(3):309-311
57. Simons FER, Gu X, Simons KJ. Outdated EpiPen and EpiPen Jr autoinjectors: past their prime? J Allergy Clin Immunol. 2000;105(5):1025-1030
58. Rachid O, Simons FER, Wein MB, Rawas-Qalaji M, Simons KJ. Epinephrine doses contained in outdated epinephrine auto-injectors collected in a Florida allergy practice. Ann Allergy Asthma Immunol. 2015;114(4):354-356, e1
59. Rachid O, Simons FER, Rawas-Qalaji M, Lewis S, Simons KJ. Epinephrine autoinjectors: does freezing or refrigeration affect epinephrine dose delivery and enantiomeric purity? J Allergy Clin Immunol Pract. 2015;3(2):294-296
60. Hernandez-Trujillo V, Simons FER. Prospective evaluation of an anaphylaxis education mini-handout: the AAAAI anaphylaxis wallet card. J Allergy Clin Immunol Pract. 2013;1(2):181-185
61. Sicherer SH, Mahr T; Section on Allergy and Immunology. Management of food allergy in the school setting. Pediatrics. 2010;126(6):1232-1239
62. ZadikoffEH, Whyte SA, Desantiago-Cardenas L, Harvey-Gintoft B, Gupta RS. The development and implementation of the Chicago public schools emergency EpiPen® policy. J Sch Health. 2014;84(5):342-347
63. Wang J, Sicherer SH; American Academy of Pediatrics, Section on Allergy and Immunology. Guidance on completing a written allergy and anaphylaxis emergency plan. Pediatrics. 2017;139(3):e20164005